These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2496130

  • 1. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
    Holder IA, Neely AN.
    J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B, Pavlovskis OR.
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [Abstract] [Full Text] [Related]

  • 4. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
    Stanislavsky ES, Dmitriev BA, Lányi B, Joó I.
    Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
    Kohzuki T, Eguchi Y, Kato M, Irie K, Ohtsuka H, Higuchi A, Noguchi H.
    J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
    [Abstract] [Full Text] [Related]

  • 7. Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.
    Fogle MR, Griswold JA, Oliver JW, Hamood AN.
    J Surg Res; 2002 Jul; 106(1):86-98. PubMed ID: 12127813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI, Iglewski BH.
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S, Tai PC.
    Curr Top Microbiol Immunol; 1985 Apr; 118():53-69. PubMed ID: 2414071
    [No Abstract] [Full Text] [Related]

  • 17. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
    O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM.
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
    [Abstract] [Full Text] [Related]

  • 18. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
    Sharma S, Kaur R, Yadav V, Harjai K, Joshi K.
    Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization.
    Martinez D, Callahan LT.
    Eur J Clin Microbiol; 1985 Apr; 4(2):186-9. PubMed ID: 3924606
    [Abstract] [Full Text] [Related]

  • 20. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
    Pitt TL.
    J R Soc Med; 1986 Apr; 79 Suppl 12(Suppl 12):13-8. PubMed ID: 2425090
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.